According to media reports, citing people familiar with the matter, Eli Lilly is in negotiations to acquire psychedelic drug manufacturer AtaiBeckley, and the deal may be announced as early as this week. AtaiBeckley shares soared 66% in after-hours trading, while Eli Lilly's shares remained flat. According to the data, AtaiBeckley has accumulated a cumulative increase of 31% so far this year, with a market capitalization of 1.97 billion US dollars as of Wednesday's close. The report said that Eli Lilly is in negotiations at a premium.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.